HMGB1 as a mediator of necrosis-induced inflammation and a therapeutic target in arthritis
- 31 August 2004
- journal article
- review article
- Published by Elsevier in Rheumatic Disease Clinics of North America
- Vol. 30 (3) , 627-637
- https://doi.org/10.1016/j.rdc.2004.04.007
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- High mobility group 1 B‐box mediates activation of human endotheliumJournal of Internal Medicine, 2003
- High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritisArthritis & Rheumatism, 2003
- HMGB1 inhibits cell death in yeast and mammalian cells and is abundantly expressed in human breast carcinomaThe FASEB Journal, 2003
- High mobility group box chromosomal protein 1 as a nuclear protein, cytokine, and potential therapeutic target in arthritisArthritis & Rheumatism, 2003
- High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokineArthritis & Rheumatism, 2003
- Receptor for Advanced Glycation End Products (RAGE) Signaling Induces CREB-dependent Chromogranin Expression during Neuronal DifferentiationJournal of Biological Chemistry, 2002
- The Significance of Changes in High Mobility Group-1 Protein mRNA Expression in Rats After Thermal InjuryShock, 2002
- The rationale for the current boom in anti-TNFα treatment. Is there an effective means to define therapeutic targets for drugs that provide all the benefits of anti-TNFα and minimise hazards?Annals of the Rheumatic Diseases, 1999
- Expression of high-mobility group-1 mRNA in human gastrointestinal adenocarcinoma and corresponding non-cancerous mucosaInternational Journal of Cancer, 1997
- Quantitative changes of high mobility group non‐histone chromosomal proteins HMG1 and HMG2 during rooster spermatogenesisFEBS Letters, 1983